Therefore, it remains unclear whether the inhibition of the mutant on CaMKII auto-phosphorylation is due to competitively binding with the cell injury initiator Ca2+/calmodulin or due to reducing endogenous CaMKII expression in ischemia/reperfusion injury. Here, CAMK2G is linked to ischemia.